Mankind Pharma results date
MANKIND · Mankind Pharma Limited· F&O stock
Updated automatically · Last refreshed 29 Oct 2026, 3:57 pm IST
Next results meeting
Not announced yet
A year ago, the same quarter's results meeting was on Thursday, 6 November 2025.
Add to my calendar · free
Never miss Mankind Pharma's results day
Add it once — every quarter's results date for Mankind Pharma lands in your calendar by itself as soon as the company announces it, and moves if the company changes it.
- Free · no sign-up
- Every quarter, automatically
- Google · Apple · Outlook
Mankind Pharma past results dates
| Quarter | Board meeting | Also considered |
|---|---|---|
| Q2 FY27 | Mon, 26 Oct 2026 | — |
| Q1 FY27 | Thu, 30 Jul 2026 | — |
| Q4 FY26 | Tue, 19 May 2026 | — |
| Q3 FY26 | Tue, 3 Feb 2026 | — |
| Q2 FY26 | Thu, 6 Nov 2025 | — |
| Q1 FY26 | Thu, 31 Jul 2025 | Dividend |
| Q4 FY25 | Wed, 21 May 2025 | — |
| Q3 FY25 | Thu, 23 Jan 2025 | — |
| Q2 FY25 | Tue, 5 Nov 2024 | — |
| Q1 FY25 | Wed, 31 Jul 2024 | — |
| Q4 FY24 | Wed, 15 May 2024 | Fund raising |
| Q3 FY24 | Wed, 31 Jan 2024 | — |
Mankind Pharma results: common questions
Mankind Pharma has not announced its next results date yet. A year ago, the same quarter's results meeting was on Thursday, 6 November 2025. The date appears here — and in your calendar, if you subscribe below — as soon as the company informs the exchange.
Mankind Pharma's last results board meeting was on Monday, 26 October 2026, for Q2 FY27.
Use "Add to my calendar" on this page. It adds a calendar of Mankind Pharma's results dates to Google, Apple or Outlook calendar, and each new quarter's date is added automatically once announced.
The Indian financial year runs from April to March: Q1 is April–June, Q2 July–September, Q3 October–December and Q4 January–March. "FY27" is the year ending March 2027.
Please note
This page updates itself every few hours. The date is the board meeting the company has announced; it can change at short notice, so please confirm in the company's exchange filings. This page is for information only — it is not a recommendation to buy, sell or hold MANKIND.